Vassilia Orfanou, PhD, Post Doc
Writes for the Headline Diplomat eMagazine, LUDCI.eu
Introduction

Artificial Intelligence (AI) has dramatically evolved in recent times, truly revolutionizing, reshaping and radically transforming lives. Switzerland – an advanced country in AI capabilities, ranks second after the US in terms of AI patents per capita and is equally ahead of France, Italy, Germany and the UK, showing first-hand how AI can turn around core sectors. This article examines the impact of AI on Swiss industries, specifically: Health and pharmaceuticals, banking and finance, education and construction.

AI Disrupts the $145 Billion Swiss and Global Pharma Sector

Financial investment in pharmaceutical research and development has steadily increased in recent years. Deloitte reported that the world's top 20 pharmaceutical companies, including, Roche and Novartis, invested US $145 billion in research and development in 2023, which is an increase of 4.5% comparatively to the previous year's investment.

The Swiss pharmaceutical industry is harnessing AI to revolutionize drug development. AI markedly speeds up the identification of potential drug candidates and enhance...

To read the whole article, please subscribe here.